Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly prescribed for weight management
The percentage of adults discontinuing the study due to an adverse event in the double-blind period was 1.8% in the tirzepatide group and 0.9% in the placebo group
Ozempic EPAR Product Information
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Rights and permissions About this article Cite this article Harrison, C
US$ 27.16
US$ 29.12
US$ 22.27
/assets/images/provider/photos/2787796.jpeg)
US$ 25.92
US$ 23.33
.webp)
